Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07536802) titled 'Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial' on April 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Institute of Cardiovascular Diseases, Pakistan
Condition:
ST-Segment Elevation Myocardial Infarction (STEMI)
No-Reflow Phenomenon
Coronary Slow Flow
Acute Myocardial Infarction
Intervention:
Drug: Adenosine pre-medication
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: June 1, 2025
Ta...